Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Propert

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The British Journal of Dermatology|October 12, 2013
The impact of skin damage due to cutaneous lupus on quality of lifeS M Verma, J Okawa, K J Propert, et al.
Cancer Treatment Reports|November 1, 1987
Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B StudyH Kreisman, S Ginsberg, K J Propert, et al.
Cancer Treatment Reports|April 1, 1986
Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group BM R Green, G Vosika, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B StudyD J Kwiatkowski, K J Propert, R W Carey, et al.
Cancer|January 1, 1997
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892)R Dreicer, K J Propert, B J Roth, et al.
Cancer Treatment Reports|May 1, 1987
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B StudyS D Luikart, K J Propert, C R Modeas, et al.
Clinical Pharmacology and Therapeutics|January 27, 2012
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649C Skarke, N Alamuddin, J A Lawson, et al.
The Journal of Pediatrics|August 4, 1999
Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopeniaM B Leonard, K J Propert, B S Zemel, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group studyR Dreicer, K J Propert, T Kuzel, et al.
Neurology|April 10, 2002
Do persons with dementia vote?J H T Karlawish, D A Casarett, B D James, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The British Journal of Dermatology|October 12, 2013
The impact of skin damage due to cutaneous lupus on quality of lifeS M Verma, J Okawa, K J Propert, et al.
Cancer Treatment Reports|November 1, 1987
Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B StudyH Kreisman, S Ginsberg, K J Propert, et al.
Cancer Treatment Reports|April 1, 1986
Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group BM R Green, G Vosika, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B StudyD J Kwiatkowski, K J Propert, R W Carey, et al.
Cancer|January 1, 1997
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892)R Dreicer, K J Propert, B J Roth, et al.
Cancer Treatment Reports|May 1, 1987
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B StudyS D Luikart, K J Propert, C R Modeas, et al.
Clinical Pharmacology and Therapeutics|January 27, 2012
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649C Skarke, N Alamuddin, J A Lawson, et al.
The Journal of Pediatrics|August 4, 1999
Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopeniaM B Leonard, K J Propert, B S Zemel, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group studyR Dreicer, K J Propert, T Kuzel, et al.
Neurology|April 10, 2002
Do persons with dementia vote?J H T Karlawish, D A Casarett, B D James, et al.
Pageof 6